Clinical Studies

Following CE Mark certification, which was obtained in September 2013, Pulsar Vascular has elected to do a post-market study in Europe. At this time, site selection is underway.

A US clinical trial under an Investigational Device Exemption (IDE) is currently enrolling patients.

As additional information on these studies becomes available, it will be posted. Please check back to this website in the future or contact us at info@pulsarvascular.com.